Efficacy of radiation countermeasures depends on radiation quality
Abstract
The detonation of a nuclear weapon or a nuclear accident represent possible events with significant exposure to mixed neutron/γ-radiation fields. Although radiation countermeasures generally have been studied in subjects exposed to pure photons (γ or X rays), the mechanisms of injury of these low linear energy transfer (LET) radiations are different from those of high-LET radiation such as neutrons, and these differences may affect countermeasure efficacy. We compared 30-day survival in mice after varying doses of pure γ and mixed neutron/γ (mixed field) radiation (MF, Dn/Dt = 0.65), and also examined peripheral blood cells, bone marrow cell reconstitution, and cytokine expression. Mixed-field-irradiated mice displayed prolonged defects in T-cell populations compared to mice irradiated with pure γ photons. In mouse survival assays, the growth factor granulocyte colony-stimulating factor (G-CSF) was effective as a (post-irradiation) mitigator against both γ-photons and mixed-field radiation, while the thrombopoietin (TPO) mimetic ALXN4100TPO was effective only against γ irradiation. The results indicate that radiation countermeasures should be tested against radiation qualities appropriate for specific scenarios before inclusion in response plans.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
4100TPO did not consistently mitigate morbidity/mortality after mixed-field irradiation unlike gamma-irradiation.
“In contrast, 4100TPO did not consistently mitigate morbidity/mortality after mixed-field irradiation unlike γ-irradiation.”
From Medical countermeasures for the hematopoietic-subsyndrome of acute radiation syndrome in space (2022) · cites this paper as Cary et al., 2012
Neupogen enhanced survival in mice from 12.5% to 68.8% compared to the vehicle control following gamma-irradiation.
“Neupogen® enhanced survival in mice from 12.5% to 68.8% compared to the vehicle control following γ-irradiation and demonstrated an equal level of mitigation of ARS after mixed-field irradiation improving survival from 19% to 75% versus the vehicle control.”
From Medical countermeasures for the hematopoietic-subsyndrome of acute radiation syndrome in space (2022) · cites this paper as Cary et al., 2012
Neupogen demonstrated an equal level of mitigation of acute radiation syndrome after mixed-field irradiation, improving survival from 19% to 75% versus the vehicle control.
“Neupogen® enhanced survival in mice from 12.5% to 68.8% compared to the vehicle control following γ-irradiation and demonstrated an equal level of mitigation of ARS after mixed-field irradiation improving survival from 19% to 75% versus the vehicle control.”
From Medical countermeasures for the hematopoietic-subsyndrome of acute radiation syndrome in space (2022) · cites this paper as Cary et al., 2012
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 70 · Cited by 41
- Authors
- Cary, L. H., Ngudiankama, B. F., Salber, R. E., Ledney, G. D., & Whitnall, M. H.
- Affiliations
- Uniformed Services University of the Health Sciences (US)
- ORCID
- Cary, Lynnette H.
- Venue
- Radiation Research
- Publisher
- Radiation Research Society
- Published
- 2012-05
- Volume
- 177
- Issue
- 5
- Pages
- 663-675
- ISSN
- 0033-7587 (ISSN-L)
- 1938-5404
- OpenAlex
- W2153515466
- Cited by
- 41
- References
- 70
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 2 · 2019: 6 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 6
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiation Research (publishedVersion)
- PubMed (publishedVersion)
- BioOne Complete (BioOne) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (YI-AI-5045)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Radiation Therapy and Dosimetry
- Physical Sciences › Engineering › Electrical and Electronic Engineering › Radiation Effects in Electronics
- Keywords
- radiation countermeasures, radiation quality, low-LET radiation, high-LET radiation, gamma irradiation, radiation-induced immunosuppression, T cell depletion, granulocyte colony-stimulating factor, thrombopoietin, bone marrow reconstitution, cytokine expression, survival after irradiation, nuclear weapons, nuclear accidents
- MeSH terms
- Filgrastim, Animals, Antibodies, Monoclonal, Bone Marrow, Bone Marrow Diseases, Drug Evaluation, Preclinical, Gamma Rays, Hematopoiesis, Hematopoietic Stem Cells, Neutrons, Radiation Injuries, Experimental, Radiation-Protective Agents, Recombinant Proteins, Spleen, T-Lymphocytes, Thrombopoietin, Granulocyte Colony-Stimulating Factor, Cytokines, Lymphocyte Count, Mice, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review